Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mortality patterns among workers exposed to acrylamide.

J J Collins1, G M Swaen, G M Marsh

  • 1American Cyanamid Company, One Cyanamid Plaza, Wayne, NJ 07470.

Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association
|July 1, 1989
PubMed
Summary

This study examined mortality risks for 8,854 men, including 2,293 exposed to acrylamide. Researchers found no significant increase in overall or cancer-specific mortality, suggesting acrylamide is not a human carcinogen.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A constrained maximum likelihood approach to evaluate the impact of dose metric on cancer risk assessment: application to β-chloroprene.

Regulatory toxicology and pharmacology : RTP·2014
Same author

Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies.

Critical reviews in toxicology·2007
Same author

Indoor environment and respiratory symptoms in children living in the Dutch-German borderland.

International journal of hygiene and environmental health·2005
Same author

Cancer dose--response assessment for acrylonitrile based upon rodent brain tumor incidence: use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity.

Regulatory toxicology and pharmacology : RTP·2005
Same author

The influence of occupational exposure to pesticides, polycyclic aromatic hydrocarbons, diesel exhaust, metal dust, metal fumes, and mineral oil on prostate cancer: a prospective cohort study.

Occupational and environmental medicine·2005
Same author

Associations between infections and fatigue in a Dutch working population: results of the Maastricht Cohort Study on Fatigue at Work.

European journal of epidemiology·2003

Area of Science:

  • Occupational health
  • Toxicology
  • Epidemiology

Background:

  • Acrylamide is a chemical used in various industrial processes.
  • Concerns exist regarding its potential carcinogenic effects in humans.
  • Previous studies have yielded inconclusive evidence on acrylamide's carcinogenicity.

Purpose of the Study:

  • To investigate the long-term mortality risks associated with occupational acrylamide exposure.
  • To determine if acrylamide exposure increases the risk of all-cause or cause-specific mortality, particularly cancer.

Main Methods:

  • A cohort study design involving 8,854 men from four plant populations in the United States and The Netherlands.
  • Mortality data was collected between 1925 and 1983 for 2,293 men with documented acrylamide exposure.

Related Experiment Videos

  • Statistical analyses were performed to assess mortality risks based on exposure levels and causes of death.
  • Main Results:

    • No statistically significant excess of all-cause mortality was observed in the acrylamide-exposed group compared to the unexposed.
    • Analysis of cause-specific mortality, including various cancer sites, did not reveal a significant increase in risk among workers exposed to acrylamide.
    • No discernible trend of increased mortality risk was associated with higher levels of acrylamide exposure.

    Conclusions:

    • The findings do not support the hypothesis that acrylamide is a human carcinogen.
    • Occupational exposure to acrylamide in this cohort was not linked to increased mortality.
    • Further research may be warranted, but current evidence suggests a lack of carcinogenic potential in humans.